Investment
Features
FeesSafety
Academy
More
Pluang+

Centrifuge launches tokenized Treasury and credit funds on Arc blockchain, expanding institutional DeFi options.

Protocol Fundamentals
02 Oct 2026
Crypto Briefing
View Source
Bullish
Centrifuge launches tokenized Treasury and credit funds on Arc blockchain, expanding institutional DeFi options.

Centrifuge has deployed three tokenized fixed-income funds from Janus Henderson and New York Life Investment Management on the Arc blockchain, which launched its public mainnet on September 16, 2026. The funds include US Treasuries, AAA-rated collateralized loan obligations, and high-yield corporate bonds, all ERC-4626 compliant for easy integration. This move broadens the range of institutional-grade yield products available on Arc, a network designed for stablecoin-native institutional finance. The addition of high-yield corporate bonds is notable for introducing higher risk and return profiles on-chain, potentially attracting more institutional capital and setting a precedent for other financial institutions.

Centrifuge's launch of tokenized Treasury and credit funds on the Arc blockchain comes as 36 out of 50 major cryptocurrencies on Pluang rose today. For readers following the crypto market, here is Pluang's market snapshot as of Oct 02, 2026 23:03 WIB: Basic Attention Token (BAT) gained 10.64% to Rp1.757 with a typical hold time of 93 days and a Pluang order activity of 86% buy. Aave (AAVE) rose 8.49% to Rp3.272.359 with a hold time of 105 days and 60% buy orders, while EOS (EOS.IO) increased 8.13% to Rp12.649 with a hold time of 87 days.

More News

Elon Musk confirms Terafab talks, expanding chip partners beyond Intel.

Elon Musk confirms Terafab talks, expanding chip partners beyond Intel.

Elon Musk has confirmed that his company is in discussions with Terafab, marking a potential new chip manufacturing partner alongside Intel, which has been the only named chip partner until now. This development could diversify the supply chain and e...

Market News
Neutral
1 hour ago
Verastem's cancer drug sales hit $25.1M in Q2 '26; key trial data expected in October

Verastem's cancer drug sales hit $25.1M in Q2 '26; key trial data expected in October

Verastem Inc. reported $25.1 million in net product revenues for Q2 2026 from its Avmapki Fakzynja Co-pack, used for certain ovarian cancer patients. The company is also developing a KRAS G12D inhibitor, VS-7375, targeting multiple cancers, with impo...

Market News
Bullish
4 hours ago
Radiant Uranium completes acquisition of Cross Lake uranium property in Saskatchewan.

Radiant Uranium completes acquisition of Cross Lake uranium property in Saskatchewan.

Radiant Uranium has finalized its acquisition of the 2,048-hectare Cross Lake uranium property in Saskatchewan's Athabasca Basin by issuing 4 million shares and paying $20,000 to Bromell Mining LLP. The property contains a historic uranium estimate o...

Company Fundamentals
Bullish
4 hours ago
Bitcoin down 32% a year after record high, milder than past crashes due to institutional flows and lower volatility

Bitcoin down 32% a year after record high, milder than past crashes due to institutional flows and lower volatility

One year after reaching a record high of over $126,000 in October 2025, Bitcoin's price has dropped just 32% to around $85,453, a much smaller decline compared to previous bear markets where drops ranged from 70% to over 80%. This milder downturn is ...

Market News
Neutral
4 hours ago
Solana launches Solana DvP, enabling instant on-chain trade settlements for institutions.

Solana launches Solana DvP, enabling instant on-chain trade settlements for institutions.

The Solana Foundation introduced Solana DvP, an open-source protocol that enables financial institutions to complete trade settlements on blockchain within seconds instead of days. Developed with guidance from JPMorgan, the protocol replaces fragment...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App